Invention Grant
US07709258B2 High throughput assay for identifying compounds capable of modulating the proliferative status of stem cells 失效
用于鉴定能够调节干细胞增殖状态的化合物的高通量测定

  • Patent Title: High throughput assay for identifying compounds capable of modulating the proliferative status of stem cells
  • Patent Title (中): 用于鉴定能够调节干细胞增殖状态的化合物的高通量测定
  • Application No.: US12049861
    Application Date: 2008-03-17
  • Publication No.: US07709258B2
    Publication Date: 2010-05-04
  • Inventor: Ivan N. Rich
  • Applicant: Ivan N. Rich
  • Applicant Address: US CO Colorado Springs
  • Assignee: HemoGenix, Inc.
  • Current Assignee: HemoGenix, Inc.
  • Current Assignee Address: US CO Colorado Springs
  • Agent Donna E. Becker
  • Main IPC: C12N5/00
  • IPC: C12N5/00
High throughput assay for identifying compounds capable of modulating the proliferative status of stem cells
Abstract:
The present invention relates generally to high-throughput assay methods that determine the proliferative status of hematopoietic stem and progenitor cells. The present invention further relates to high-throughput assays for screening compounds that modulate the growth of hematopoietic stem and progenitor cells and for identifying subpopulations thereof that are suitable for transplantation. The assay of the present invention is particularly useful for quality control and monitoring of the growth potential in the stem cell transplant setting and would provide improved control over the reconstitution phase of transplanted cells.
Information query
Patent Agency Ranking
0/0